n-demethylloperamide and Drug-Overdose

n-demethylloperamide has been researched along with Drug-Overdose* in 2 studies

Other Studies

2 other study(ies) available for n-demethylloperamide and Drug-Overdose

ArticleYear
Loperamide metabolite-induced cardiomyopathy and QTc prolongation.
    Clinical toxicology (Philadelphia, Pa.), 2017, Volume: 55, Issue:7

    Loperamide is an over-the-counter, peripherally acting, μ-opioid receptor agonist used for the treatment of diarrhea. In recent times users have found that at higher doses, loperamide crosses the blood-brain barrier and reaches central μ-receptors in the brain, leading to central opiate effects including euphoria and respiratory depression. We report a case of a 37-year-old female who attempted suicide with over 200 loperamide tablets. During her overdose, her QTc was significantly prolonged at >600 ms. Our case aims to add to the growing body of literature describing life-threatening ventricular arrhythmias associated with loperamide toxicity and further suggests that a metabolite of loperamide, desmethylloperamide, may play a role in the pathogenesis.

    Topics: Adult; Antidiarrheals; Biotransformation; Cardiomyopathies; Drug Overdose; Electrocardiography; Female; Humans; Long QT Syndrome; Loperamide; Predictive Value of Tests; Suicide, Attempted

2017
Tissue distribution of loperamide and N-desmethylloperamide following a fatal overdose.
    Journal of analytical toxicology, 2005, Volume: 29, Issue:7

    We report a case involving a fatal intoxication with loperamide (Imodium). Loperamide is a synthetic opioid of the phenyl piperidine class used as an over-the-counter antidiarrheal. It exerts its effects through interaction with micro-opiate receptors in the intestine to reduce peristalsis. Loperamide lacks the typical euphoric opiate effects when administered at recommended doses. Both loperamide and its major metabolite, N-desmethylloperamide, were isolated by liquid-liquid extraction into n-butyl chloride from alkalinized samples. Extracts were analyzed by liquid chromatography-electrospray-mass spectrometry in selected-ion-monitoring mode. Rapid separation of the drug, metabolite, and internal standard (diphenoxylate) was achieved using a high-resolution C18 column with 1.8-microm particle diameter. The mobile phase consisted of 0.1% formic acid in deionized water (60%) and acetonitrile (40%) at a flow rate of 0.5 mL/min. Heart blood concentrations for loperamide and its metabolite were 1.2 mg/L and 3.3 mg/L, respectively. In contrast, reported peak plasma concentrations of loperamide after administration of recommended daily doses of 16 mg did not exceed 0.012 mg/L in controlled trials. Because the heart blood ethanol concentration was 0.08 g/dL, the medical examiner ruled that the cause of death was loperamide and ethanol intoxication, and the manner of death as undetermined.

    Topics: Adult; Antidiarrheals; Chromatography, High Pressure Liquid; Drug Overdose; Fatal Outcome; Forensic Pathology; Humans; Loperamide; Male; Tissue Distribution

2005